The critical role of p38 MAP kinase in T cell HIV-1 replication

Molecular Medicine

Volumn 3, Issue 5, 1997, Pages 339-346

  Cohen, Pamela S ^a   Schmidtmayerova, Helena ^a,c   Dennis, Jameel ^a,b   Dubrovsky, Larisa ^a   Sherry, Barbara ^a   Wang, Haichao ^a,b   Bukrinsky, Michael ^a   Tracey, Kevin J ^a,b  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0030803470     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401812     Document Type: Article

References (30)

1. Collier AC, Coombs RW, Schoenfeld DA, et al. (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N. Engl. J. Med. 334: 1011-1017.
2. Eron JJ, Benoit SL, Jemsek J, et al. (1995) Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party [see comments]. N. Engl. J. Med. 333: 1662-1669.
3. Deeks S, Volberding P. (1995) An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role. Hosp. Pract. (Off. Ed). 30 (Suppl 1): 23-31.
4. Fauci AS, Pantaleo G, Stanley S, Weissman D. (1996) Immunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124: 654-663.
5. Heguy A, Stewart AA, Haley JD, Smith DE, Foulkes JG. (1995) Gene expression as a target for new drug discovery. Gene Expr. 4: 337-344.
6. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86: 5974-5978.
7. Osborn L, Kunkel S, Nabel GJ. (1989) Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U.S.A. 86: 2336-2340.
8. Han J, Lee J-D, Bibbs L, Ulevitch RJ. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811.
9. Lee JC, Laydon JT, McDonnell PC, et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746.
10. Raingeaud J, Gupta S, Rogers JS, et al. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270: 7420-7426.
11. Shapiro L, Dinarello CA. (1996) Specific inhibition of p38 mitogen activated protein (MAP) kinase inhibits in vitro HIV replication in U1 cells induced by interleukin (IL)-1, tumor necrosis factor (TNF) or phorbol esters (PMA). Eur. Cytokine Netw. 7(3): 557.
12. Kumar S, Orsini M, Lee J, McDonnell P, Debouck C, Young P. (1996) Activation of the HIV LTR by UV, cytokines and high osmolarity requires CSBP/p38 activation. Eur. Cytokine Netw. 7(3): 558.
13. Sen J, Kapeller R, Fragoso R, Sen R, Zon LI, Burakoff SJ. (1996) Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J. Immunol. 156: 4535-4538.
14. Han J, Richter B, Li Z, Kravchenko V, Ulevitch RJ. (1995) Molecular cloning of human p38 MAP kinase. Biochim. Biophys. Acta 1265: 224-227.
15. Bianchi M, Ulrich P, Bloom O, et al. (1995) An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1: 254-266.
16. Bianchi M, Bloom O, Raabe T, et al. (1995) Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 183: 927-936.
17. Cohen PS, Nakshatri H, Dennis J, et al. (1996) CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc. Natl. Acad. Sci. U.S.A. 93: 3967-3971.
18. Kumar S, Orsini MJ, Lee JC, McDonnell PC, Debouck C, Young PR. (1996) Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J. Biol. Chem. (In Press).
19. Lu X, Wu X, Plemenitas A, et al. (1996) CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6: 1677-1684.
20. Nunn MF, Marsh JW. (1997) Human immunodeficiency virus type 1 NEF associates with a member of the p21-activated kinase family. J. Virol. 70: 6157-6161.
21. Sawai ET, Khan IH, Montbriand PM, et al. (1996) Activation of PAK by HIV and SIV Nef: Importance for IADS in Rhesus macaque. Curr. Biol. 6: 1519-1527.
22. Batchvarova N, Wang XZ, Ron D. (1995) Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14: 4654-4661.
23. Freshney NW, Rawlinson L, Guesdon F, et al. (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78: 1039-1049.
24. Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R. (1995) Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc. Natl. Acad. Sci. U.S.A. 92: 10531-10534.
25. Trono D. (1995) HIV accessory proteins: Leading roles for the supporting cast. Cell 82: 189-192.
26. Yang X, Goncalves J, Gabuzda D. (1996) Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem. 271: 10121-10129.
27. Heinzinger NK, Bukinsky MI, Haggerty SA, et al. (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U.S.A. 91: 7311-7315.
28. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
29. Flory E, Hoffmeyer A, Smola U, Rapp UR, Bruder JT. (1996) Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J. Virol. 70: 2260-2268.
30. Kaplan G, Moreira AL. (1994) TNF alpha regulation of HIV1: Biology and therapy. Res. Immunol. 145: 685-689.